Merck bets on flu prevention with $9.2 billion deal for Cidara Therapeutics
Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, gaining access to an experimental flu drug in its effort to diversify ahead of patent loss for its
November 14, 2025
Community rallies behind teacher hit while helping stranded driver
More kids than ever are attending state-funded preschool, with California's surge leading the way
Man who swiped Noem's purse in a DC restaurant is sentenced to 3 years in prison
At far-right event, France's Bardella targets Spain over migrant amnesty
Brazil's BRB shareholders approve $1.8 billion capital increase
EU may let startups claim innovation benefits in M&A if Big Tech not involved
Oklahoma couple recreates quarter-century-old trip on Route 66 at Navy Pier
United Airlines says fares may need to rise up to 20% to offset fuel surge
Trump administration nears deal to rescue Spirit Airlines, WSJ reports